Resource Library

The purpose of this ACC guide (InfoPAK) is to provide an overview of opportunities available as a result of Big Data — the ability to collect, process, and interpret massive amounts of information — in healthcare, and the U.S. regulatory regime that is in part driving such industry change. It provides an overview of the key US federal and state laws pertaining to the collection and secondary use of health data, and suggests strategies and best practices for addressing health privacy and data ownership concerns.

This InfoPAK provides essential legal and practical advice about cloud computing and its increasing use in the health care industry. It explores in depth the primary legal risks associated with hosting and accessing clinical data in the cloud computing environment, including the privacy and security issues associated with the use of cloud technology. Also included in this InfoPAK is a comprehensive discussion of cloud computing contracting issues, strategies for successfully negotiating cloud agreements, and sample contract provisions for “best practice” solutions. This InfoPAK also provides valuable checklists and tools to guide health care organizations in negotiating cloud computing agreements.

This is a list of Missouri & Federal Data Retention and Destruction Common Sources

This is a sample HIPPA Privacy Policy

This chart leads the user through the employer mandate penalties under health care reform set to begin in 2015.

This article provides practical guidance on a number of key issues related to contracting with physicians and other referral sources.

This guide presents a general overview of health law in jurisdictions throughout the world.

In recent years, the compliance landscape for health industry companies has become more
complex, in part because of increasingly aggressive enforcement of privacy breaches and false claims by regulators. At the same time, unprecedented pushes for transparency and disclosure by both the government and the public continue to gain traction. This Practice Profile highlights elements presented by four healthcare organizations as crucial for responding to these trends and nurturing successful compliance programs. Organizational leaders featured here explain department leading practices designed to bolster cultures of compliance while better managing risk and encouraging innovation. They also offer their best practices in areas that can inform your own organization’s approach to compliance, its pursuit of an excellence culture and its effective reliance on outside counsel in responding to
government inquiries.

This Quick Overview addresses how the Precision Medicine Initiative (the "PMI") allows targeted therapies to be deployed that are more likely to be efficacious, less likely to lead to adverse side effects, and, in many circumstances, more cost-effective for both the patient and society at large than current approaches to many different illnesses.

This quick overview (QuickCounsel) describes how the U.S. Food and Drug Administration ("FDA") regulates the pre-marketing process for drugs and medical devices, and the steps that must be taken to obtain FDA authorization to market these products.